Literature DB >> 3291939

Indomethacin retinopathy: case report and review.

C M Graham1, R K Blach.   

Abstract

The case of a 33-year-old man with probable indomethacin retinopathy is presented. The relevant literature is reviewed and the differences between our case and those previously reported are noted. Our patient appears to have suffered severe and irreversible ocular damage due to the very high dose of indomethacin ingested over a prolonged period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3291939      PMCID: PMC1041477          DOI: 10.1136/bjo.72.6.434

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Electrophysiological findings in patients treated with indomethacin.

Authors:  G Palimeris; J Koliopoulos; P Velissaropoulos
Journal:  Adv Exp Med Biol       Date:  1972       Impact factor: 2.622

2.  On acquired colour vision disturbances during treatment with ethambutol and indomethacin.

Authors:  J Koliopoulos; G Palimeris
Journal:  Mod Probl Ophthalmol       Date:  1972

3.  Ocular side effects of indomethacin.

Authors:  G Palimeris; J Koliopoulos; P Velissaropoulos
Journal:  Ophthalmologica       Date:  1972       Impact factor: 3.250

4.  Indomethacin retinopathy.

Authors:  H E Henkes; G H van Lith; L R Canta
Journal:  Am J Ophthalmol       Date:  1972-06       Impact factor: 5.258

5.  Indomethacin induced ocular toxicity.

Authors:  C A Burns
Journal:  Am J Ophthalmol       Date:  1973-08       Impact factor: 5.258

6.  Retinal function in patients treated with indomethacin.

Authors:  R E Carr; I M Siegel
Journal:  Am J Ophthalmol       Date:  1973-02       Impact factor: 5.258

7.  Electrodiagnostic procedures in drug-induced ocular diseases.

Authors:  H E Henkes; A F Deutman
Journal:  Doc Ophthalmol       Date:  1973-02-21       Impact factor: 2.379

8.  Acquired color vision defects secondary to retinal drug toxicity.

Authors:  P Grützner
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

9.  Indomethacin, reduced retinal sensitivity, and corneal deposits.

Authors:  C A Burns
Journal:  Am J Ophthalmol       Date:  1968-11       Impact factor: 5.258

  9 in total
  2 in total

Review 1.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

Review 2.  Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.

Authors:  Rosanna Dammacco; Silvana Guerriero; Giovanni Alessio; Franco Dammacco
Journal:  Int Ophthalmol       Date:  2021-11-21       Impact factor: 2.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.